Chemotherapy
A total of 82 (57.3%) patients completed therapy (surgery chemotherapy and radiotherapy), while 53 (37%) did not. The event-free survival among patients who completed treatment is 75.6%, and the overall survival is 43.4%. See figure 1 and figure 2. Survival among patients who completed chemotherapy, surgery, and radiotherapy is significantly better than who did not p < .01 No chemotherapy was given to 8(6%) patients because they were lost for follow-up or refused treatment. One patient was given chemotherapy for palliation.
The actuarial survival is 100 % for stage I, 73.3% for stage II (censored), and 57 % for stage III (censored) 55% for stage IV and 16.7% for stage V.